CATRAMILAST

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C17H22N2O3
Molecular Weight	302.3682
Optical Activity	UNSPECIFIED
Defined Stereocenters	1 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

COC1=CC=C(C=C1OCC2CC2)[C@H](C)CN3C=CNC3=O

InChI

InChIKey=ACBYRQONKZKIIY-GFCCVEGCSA-N

InChI=1S/C17H22N2O3/c1-12(10-19-8-7-18-17(19)20)14-5-6-15(21-2)16(9-14)22-11-13-3-4-13/h5-9,12-13H,3-4,10-11H2,1-2H3,(H,18,20)/t12-/m1/s1

HIDE SMILES / InChI

Molecular Formula	C17H22N2O3
Molecular Weight	302.3682
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	1 / 1
E/Z Centers	0
Optical Activity	UNSPECIFIED

Description
Sources: https://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=19961010&CC=WO&NR=9631485A1&KC=A1 | https://chemport.cas.org/cgi-bin/cp_sdcgi?1C74isVRGg41RVthQiUyxJPUt8vWa8SQrYmJCSZgSUu4Xd2IXHQapTUnWaFfXF34lKcoJH@SJfRPo@yuGcD8RKr3I9dx5G7vr7HoMFb0josDQ5TuPG@rhBeQ9pdAauDJ7aktpFwHrTm@rEhz2GhTU8mI7UT7gRKZTMIy

Catramilast is imidazolone derivative patented by Janssen Pharmaceutica N.V. as PDE IV inhibitor for the treatment of allergic, atopic, and inflammatory diseases.

Originator

Approval Year

Patents

Substance Class	Chemical Created by `admin` on `Mon Mar 31 18:20:43 GMT 2025` Edited by `admin` on `Mon Mar 31 18:20:43 GMT 2025`
Record UNII	QVZ4XA556B
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

CATRAMILAST

Official Name

English

R-115500

Preferred Name

English

Catramilast [WHO-DD]

Common Name

English

R/115500

Code

English

1-[(2S)-2-[3-(Cyclopropylmethoxy)-4-methoxyphenyl]propyl]-1,3-dihydro-2H-imidazol-2-one

Systematic Name

English

R115500

Code

English

CATRAMILAST [USAN]

Common Name

English

catramilast [INN]

Common Name

English

2H-IMIDAZOL-2-ONE, 1-(2-(3-(CYCLOPROPYLMETHOXY)-4-METHOXYPHENYL)PROPYL)- 1,3-DIHYDRO-, (S)-

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C744